Release Date: 21/03/22 14:31 Summary: Loyalty Options - Amended Timetable Price Sensitive: No Download Document 152.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%